Figure 2 of the manuscript shows clear florescence intensity differences between the tumor and the normal pancreas with a tumor-to-normal pancreas ratio of 1.37–1.47 after MUC4-IR800 targeting. This evidence concerns the gene MUC4 and neoplasm.